论文信息 - Phase I pharmacokinetic (PK), and pharmacodynamic (PD) trial of the novel oral Notch inhibitor MK-0752 in patients (pts) with advanced breast cancer (BC) and other solid tumors. - 字舞流文

Phase I pharmacokinetic (PK), and pharmacodynamic (PD) trial of the novel oral Notch inhibitor MK-0752 in patients (pts) with advanced breast cancer (BC) and other solid tumors.

E. Winer | P. LoRusso | M. Kosh | I. Krop | A. Dallob | S. Freedman | C. Matthews | J. Savoie | I. Fearen | J. Stone | Eric P. Winer | E. Winer | Patricia M. LoRusso | Aimee Dallob | Catherine Z. Matthews | James R. Stone | Steven J. Freedman | Patricia LoRusso